Literature DB >> 25031775

Pulmonary mucormycosis with embolism: two autopsied cases of acute myeloid leukemia.

Yasunori Kogure1, Fumihiko Nakamura1, Aya Shinozaki-Ushiku2, Akira Watanabe3, Katsuhiko Kamei3, Tetsuichi Yoshizato1, Yasuhito Nannya1, Masashi Fukayama2, Mineo Kurokawa4.   

Abstract

Mucormycosis is an increasingly important cause of morbidity and mortality for patients with hematological malignancies. The diagnosis of mucormycosis usually requires mycological evidence through tissue biopsy or autopsy because the signs and symptoms are nonspecific and there are currently no biomarkers to identify the disease. We herein present two autopsied cases of acute myeloid leukemia with prolonged neutropenia who developed invasive mucormycosis accompanied by pulmonary artery embolism. Our cases were featured by unexplained fever and rapidly progressive dyspnea. Computed tomography scan detected nodular lesions or nonspecific consolidations in the lungs. Cultures, cytological study, and serum fungal markers consistently gave negative results. Autopsy revealed embolism of the pulmonary artery which consisted of fibrin clots by filamentous fungi. Genomic DNA was extracted from the paraffin-embedded clots and was applied to polymerase chain reaction amplification, leading to the diagnosis of infection by Rhizopus microsporus. We should carefully search for life-threatening pulmonary embolism when patients with hematological malignancies develop pulmonary mucormycosis.

Entities:  

Keywords:  Rhizopus microsporus; acute myeloid leukemia; mucormycosis; neutropenia; pulmonary embolism

Mesh:

Substances:

Year:  2014        PMID: 25031775      PMCID: PMC4097268     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  11 in total

Review 1.  Invasive mycoses: strategies for effective management.

Authors:  Dimitrios P Kontoyiannis
Journal:  Am J Med       Date:  2012-01       Impact factor: 4.965

2.  Multiple pulmonary arteriolar emboli in a patient with disseminated mucormycosis and myelodysplastic syndrome.

Authors:  A Ono; F Okada; Y Ando; T Maeda; Y Saburi; Y Kondo; H Mori
Journal:  Clin Radiol       Date:  2011-07-13       Impact factor: 2.350

Review 3.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Authors:  Maureen M Roden; Theoklis E Zaoutis; Wendy L Buchanan; Tena A Knudsen; Tatyana A Sarkisova; Robert L Schaufele; Michael Sein; Tin Sein; Christine C Chiou; Jaclyn H Chu; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2005-07-29       Impact factor: 9.079

Review 4.  How I treat mucormycosis.

Authors:  Dimitrios P Kontoyiannis; Russell E Lewis
Journal:  Blood       Date:  2011-05-26       Impact factor: 22.113

5.  Unusual pulmonary embolism: septic pulmonary embolism and amniotic fluid embolism.

Authors:  Masahito Sakuma; Koichiro Sugimura; Mashio Nakamura; Tohru Takahashi; Osamu Kitamukai; Takahiro Yazu; Norikazu Yamada; Masahiro Ota; Takao Kobayashi; Takeshi Nakano; Kunio Shirato
Journal:  Circ J       Date:  2007-05       Impact factor: 2.993

Review 6.  Mucormycosis in hematologic patients.

Authors:  Livio Pagano; Massimo Offidani; Luana Fianchi; Annamaria Nosari; Anna Candoni; Marco Picardi; Laura Corvatta; Domenico D'Antonio; Corrado Girmenia; Pietro Martino; Albano Del Favero
Journal:  Haematologica       Date:  2004-02       Impact factor: 9.941

7.  Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases.

Authors:  Jo-Anne H van Burik; Roberta S Hare; Howard F Solomon; Michael L Corrado; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2006-02-21       Impact factor: 9.079

8.  Disseminated Cunninghamella bertholletiae infection with septic pulmonary embolism after allogeneic bone marrow transplantation.

Authors:  K Matsumoto; W Yamamoto; E Ohgusa; M Tanaka; A Maruta; Y Ishigatsubo; H Kanamori
Journal:  Transpl Infect Dis       Date:  2014-03-05       Impact factor: 2.228

Review 9.  Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment.

Authors:  R M Prabhu; R Patel
Journal:  Clin Microbiol Infect       Date:  2004-03       Impact factor: 8.067

10.  Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.

Authors:  Mitsutoshi Kurosawa; Masakatsu Yonezumi; Satoshi Hashino; Junji Tanaka; Mitsufumi Nishio; Makoto Kaneda; Shuichi Ota; Kyuhei Koda; Nobuhiro Suzuki; Makoto Yoshida; Yasuo Hirayama; Rishu Takimoto; Yoshihiro Torimoto; Akio Mori; Tohru Takahashi; Susumu Iizuka; Tadao Ishida; Ryoji Kobayashi; Takanori Oda; Hajime Sakai; Satoshi Yamamoto; Fumihiko Takahashi; Takashi Fukuhara
Journal:  Int J Hematol       Date:  2012-10-31       Impact factor: 2.490

View more
  2 in total

1.  Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome.

Authors:  Jun Feng; Xuefeng Sun
Journal:  Infection       Date:  2018-05-10       Impact factor: 3.553

2.  Isolated pulmonary mucormycosis in an immunocompetent patient: a case report and systematic review of the literature.

Authors:  Jianhan He; Gaohong Sheng; Huihui Yue; Fengqin Zhang; Hui-Lan Zhang
Journal:  BMC Pulm Med       Date:  2021-04-27       Impact factor: 3.317

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.